Toronto, January 12th, 2020 – Atlas365 Inc. is thrilled to announce it has successfully raised a funding round after oversubscribing its anticipated raise of $500,000. The round was led by strategic investor Canxtra Inc., a global industrial-scale cannabis extractor and product manufacturer. Friends and family supplemented the round.
The new investment round will enable Canurta Inc. to commercialize a novel, cannabinoid-free extract and introduce it to the market for the first time. Driven by a need to understand the compounds responsible for many of the cannabis benefits that are currently being researched, Atlas365 Inc., working with researchers from the University of Guelph, aimed to understand novel cannabis polyphenols and developed a proprietary extraction method to isolate, capture and purify these valuable compounds.
The resulting Canurta extract is enriched with an exclusive blend of these hemp-derived polyphenols. It requires no cannabinoids or terpenes to give it its synergistic effect. Polyphenols have long been researched for their beneficial effects, including anti-inflammatory, neuroprotective, anti-cancer, anti-bacterial, antiviral, and hepatoprotective. Moreover, cannabis polyphenols exhibit novel properties that may help enhance the quality of life, support long-term well-being, and aid in living a healthy and active lifestyle by encouraging normal muscle and joint function, promoting recovery, and improving performance. By offering CanurtaTM in various human and animal natural health products, including dietary supplements, cosmeceuticals, and nutraceuticals, the extract looks to disrupt the current cannabinoid market.
Click here to read the full press release.